Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Market Cap	32.57B -5.7%
Revenue (ttm)	7.10B +13.1%
Net Income	1.52B +14.5%
EPS	13.59 +14.5%
Shares Out	111.93M
PE Ratio	21.41
Forward PE	19.37
Dividend	5.20 (1.75%)
Ex-Dividend Date	n/a

Volume	216,616
Average Volume	167,178
Open	297.35
Previous Close	297.35
Day's Range	289.90 - 297.35
52-Week Range	259.00 - 366.25
Beta	0.35
RSI	46.10
Earnings Date	May 15, 2026

About NSE:ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 338
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In fiscal year 2025, NSE:ADVENZYMES's revenue was 6.37 billion, an increase of 2.09% compared to the previous year's 6.24 billion. Earnings were 1.31 billion, a decrease of -1.64%.